Skip to content

Supporting Clinicians to Fund MedTech Innovation.

We Bring Together

Clinicians

Interested in investing in an area where they have clinical expertise

MedTech Innovation

Who need funding and other early stage supports

Trusted By Industry Leaders

Clinicians as Investors

Exclusive access to early stage MedTech Innovations
Invest from $10,000 up to $500,000
Invest in pre-vetted companies
Self-directed Investments
Risk diversification
Optional consultancy and collaboration roles

For MedTech Startups

Access to a network of clinical investors
Investor readiness vetting
Pitch and slide deck design and presentation skills
Clinical evaluation of technology
Source key opinion leaders and non-executive directors
Due diligence for future investment

Benefits of Syndicates

Deep Sector Specialism

Our syndicates are clinical led providing a clinical evaluation.

Risk Diversification

Multiple clinicians investing diversifies the risk for investors and increases benefits to the company.

Improved Offer Evaluation

More Investors leads to more robust clinical evaluation.

Post investment evaluation

Clinical investors provide the clinical evaluation that professional investors require.

Global Reach

International investors can help advise on a multitude of markets, their access and reimbursement.

Accelerating Time to Market

Clinical backing will support earlier market acceptance of technology.

Important Message IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON MEDTECH SYNDICATES ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.

www.MedtechSyndicates.com is a website owned and operated by MedTech Syndicates LLC, (“Medtech Syndicates”), which is neither a registered broker-dealer, investment advisor, nor funding portal.

Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of Medtech Syndicates: ICON Capital Group LLC, a member of the Financial Industry Regulatory Authority FINRA / SIPC. You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. 

Medtech Syndicates facilitates three types of primary offerings:

Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through ICON Capital Group LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through ICON Capital Group LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through ICON Capital Group LLC Some of these offerings are open to the general public, however there are important differences and risks.

Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. Medtech Syndicates and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice concerning any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. Medtech Syndicates does not verify the adequacy, accuracy, or completeness of any information. Neither Medtech Syndicates nor any of its officers, directors, agents, and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site.

Investing in private company securities is not suitable for all investors. An investment in private company securities is highly speculative and involves a high degree of risk. It should only be considered a long-term investment. You must be prepared to withstand a total loss of your investment. Private company securities are also highly illiquid, and there is no guarantee that a market will develop for such securities. Each investment also carries its own specific risks, and you should complete your own independent due diligence regarding the investment. This includes obtaining additional information about the company, opinions, financial projections, and legal or other investment advice. Accordingly, investing in private company securities is appropriate only for those investors who can tolerate a high degree of risk and do not require a liquid investment. See additional general disclosures here.

By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.